30
Participants
Start Date
December 6, 2017
Primary Completion Date
December 31, 2021
Study Completion Date
December 31, 2021
Ripasudil hydrochloride hydrate 0.4% ophthalmic solution
"the ophthalmic solution will be administered three or six per times per day in the eye designated as the Study Eye upon study enrollment"
RECRUITING
NorthShore University HealthSystem, Glenview
Marian Macsai, MD
OTHER